Phychem Technologies IPO Analysis: Should You Apply? GMP, Review & Details

Phychem Technologies is a SME IPO in the IT Enabled Services sector. The issue price band is ₹51.0–₹54.0 per share. Issue size is ₹14.58 crore. Current GMP is +1.85% over the issue price (unofficial, subject to change).

Phychem Technologies IPO — Key Details

Company Overview

Phychem Technologies is involved in the manufacturing of rotational molding compounds, which are essential raw materials for producing various hollow plastic products. The company offers a range of customized polyethylene-based compounds, including those made from LLDPE and HDPE, supplied in powder or granule form. Their products serve multiple industries such as construction, water management, agriculture, automotive, and consumer goods. Phychem also provides custom-molded tanks and jobwork services, and is recognized as a One Star Export House, exporting to several countries.

Financial Performance

Revenue was ₹47.59 Cr in the year ending 31 Mar 2024, rising to ₹51.11 Cr by 31 Mar 2025, and further increasing to ₹57.48 Cr by 31 Mar 2026. This indicates a steady growth in total income over the periods. Profit After Tax was ₹1.69 Cr for the year ending 31 Mar 2024, increasing to ₹2.84 Cr by 31 Mar 2025, and reaching ₹4.09 Cr by 31 Mar 2026. This shows a positive trend in profitability across the reported periods.

Objects of the Issue

The Company proposes to utilize the Net Proceeds from the Issue towards the following objects: 1. Repayment in full or in part of certain outstanding borrowings (₹2.50 Cr), 2. Funding capital expenditure towards procurement of plant and machinery (₹5.15 Cr), 3. General Corporate Purposes (Total: ₹7.65 Cr).

Strengths & Weaknesses

Strengths

Phychem Technologies has a wide range of products for diverse applications in the roto molding industry, long-standing relationships with customers across various geographies, an in-house manufacturing facility with advanced machinery, and a strong focus on quality and safety.

Understanding Grey Market Premium (GMP)

The Grey Market Premium (GMP) is an unofficial indicator of the potential listing gains of an IPO. It reflects the demand and supply for the shares in the grey market before they are officially listed on the stock exchange. A positive GMP suggests that the market expects the stock to list at a higher price than the issue price.

Subscription Status

As of 2nd Sep 2026, the IPO was subscribed 20.79 times overall. The Institutional category saw a subscription of 4.31 times, while the Non-Institutional Investors (NII) category was heavily subscribed at 42.41 times. Retail investors subscribed 20.76 times, indicating strong interest across all categories.

IPO Timeline

The IPO opens on 31 August 2026 and closes on 2 September 2026. Allotment of shares will be done on 3 September 2026, with the listing date scheduled for 7 September 2026.

Should You Apply for Phychem Technologies IPO?

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. Factors to consider include the company's growth potential, financial health, and market conditions.

Investors who are risk-averse or prefer stable returns may want to avoid IPOs like this, which can be subject to significant price fluctuations on listing day and in the initial trading period.

This is general risk-profile education, not a personal recommendation to apply or avoid this specific IPO — TopFund is not a SEBI-registered investment adviser.

Listing Day Risks

Investing in IPOs can involve risks, particularly regarding listing-day gains. While some investors may experience immediate profits if the stock opens at a higher price than the issue price, others may face losses if the stock price declines after listing. Market conditions, investor sentiment, and company performance can all affect listing-day outcomes.

Trending Searches

Disclaimer: This is educational content, not investment advice. GMP is an unofficial grey-market indicator, unregulated and never guaranteed. TopFund is not a SEBI-registered investment adviser — please do your own research or consult a qualified adviser before applying to any IPO.